User banner image
User avatar
  • admin

Posts

Beyond Bank and Cognizant join forces to lead the future of customer-owned banking

Beyond Bank Australia leverages Cognizant’s expertise to modernize IT infrastructure and enhance operational resilience. SYDNEY and TEANECK, N.J., Dec. 11, 2024 /PRNewswire/ — Cognizant (NASDAQ: CTSH) has...

Fintech Abu Dhabi Unites Global Tech Leaders, Reaffirms Abu Dhabi as a Hub for Financial Innovation

ABU DHABI, UAE, Dec. 12, 2024 /PRNewswire/ — Fintech Abu Dhabi returned for its highly anticipated eighth edition, reinforcing its status as the Middle East’s biggest...

The Saudi Tourism Authority : ‘Saudi, Welcome to Arabia’ Gears Up to Welcome the World for FIFA World Cup™ 2034

RIYADH, Saudi Arabia, Dec. 12, 2024 /PRNewswire/ — Following the official announcement of Saudi as the host country for the FIFA World Cup™ 2034 today,...

Non-Surgical Skin Tightening Devices Industry Research 2024-2030: Use in Facial Rejuvenation Expands Addressable Market for Skin Tightening Devices

Understand the significant growth trajectory of the Laser-based Devices segment, which is expected to reach US$391.1 Million by 2030 with a CAGR of a 4.7%....

Broccoli Powder Market Forecast Report 2024-2029, Featuring Profiles of Saipro Biotech, NutraDry, Adya Organics, Pioneer Herb Industrial, VDF FutureCeuticals, Vinayak Ingredients, Vehgro and More

Global Broccoli Powder Market Projected to Surge, Reaching USD 67.43 Million by 2029 Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) — The “Broccoli Powder Market –...

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

MALVERN, Pa., Dec. 11, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing...

GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors

Former CEO of NPS Pharma brings strong biotech expertise to further accelerate GEn1E’s development and commercialization of dual signal modulators as novel precision therapies PALO...

Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients

Extensive Scientific Evidence Supporting Growth Factor Receptor Bound Protein-2 (Grb2) as Fundamental Link in Insulin Resistance Reallocates Resources to Metabolic Program and Discontinues Enrollment in...

Tilray Canada Launches THC Beverage Holiday Campaign Featuring XMG and Mollo Brands for Festive Season Celebrations

TORONTO, Dec. 11, 2024 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer packaged goods company, today announced a...

Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Breast Cancer

CDK2-directed MGD drove deep tumor regression in preclinical models of HR-positive/HER2-negative breast cancer when combined with either a CDK4/6 inhibitor or a CDK4/6 inhibitor and...